(Q40620314)

English

Phase II non-randomized study of three different sequences of docetaxel and vinorelbine in patients with advanced non-small cell lung cancer

scientific article published on December 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Phase II non-randomized study of three different sequences of docetaxel and vinorelbine in patients with advanced non-small cell lung cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

1 reference

based on heuristic

inferred from title

9

object named as

Rafael Rosell

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

author name string

José Miguel Sánchez

1

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Carme Balañá

2

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Albert Font

3

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

José Javier Sánchez

4

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

José Luis Manzano

5

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Mónica Guillot

6

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Mireia Margelí

7

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Martin Richardet

8

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

publication date

1 December 2002

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

38

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

309-315

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900220-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial of vinorelbine compared with fluorouracil plus leucovorin in patients with stage IV non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900220-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung cancer: a Southwest Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900220-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I/II study of escalating doses of vinorelbine in combination with oxaliplatin in patients with advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900220-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non--small-cell lung cancer: a Southwest Oncology Group trial

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900220-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A multicenter, randomized, phase III study of docetaxel plus best supportive care versus best supportive care in chemotherapy-naive patients with metastatic or non-resectable localized non-small cell lung cancer (NSCLC).

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900220-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900220-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900220-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Oncoprotein 18 overexpression increases the sensitivity to vindesine in the human lung carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900220-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I dose-finding and pharmacokinetic study of docetaxel and vinorelbine as first-line chemotherapy for metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900220-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I trial of docetaxel and vinorelbine in patients with advanced nonsmall cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900220-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial of docetaxel and vinorelbine in patients with advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900220-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase II study of docetaxel and vinorelbine combination chemotherapy in patients with advanced non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900220-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I/II trial of docetaxel and vinorelbine in patients with non-small cell lung cancer previously treated with platinum-based chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900220-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Weekly docetaxel with either gemcitabine or vinorelbine as second-line treatment in patients with advanced nonsmall cell lung carcinoma: Phase II trials of the Minnie Pearl Cancer Research Network

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900220-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Pilot study of sequential vinorelbine and cisplatin followed by docetaxel for selected IIIB and stage IV non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900220-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0169-5002(02)00220-9

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40620314&oldid=2047614561"